XTNT
$1.49
Xtant Medical Holdings
($.08)
(5.10%)
XTNT
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Thursday
Oct 29
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when XTNT reports earnings?
Beat
Meet
Miss

Where is XTNT's stock price going from here?
Up
Flat
Down
Stock chart of XTNT
Analysts
Summary of analysts' recommendations for XTNT
Score
Grade
Pivots
Resistance
$1.77
$1.71
$1.64

$1.58

Support
$1.51
$1.46
$1.39
Tweet
Growth
Description
Xtant Medical Holdings, Inc. develops, manufactures and markets biologics products. The Company's product used in an applications which includes enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries. Xtant Medical Holdings, Inc., formerly known as Bacterin International Holdings, Inc., is based in Belgrade, United States.